Icure Pharmaceutical Incorporation (KOSDAQ: 175250)

Icure Pharmaceutical Incorporation Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	72,908	78,103	79,498	338,828	467,315	233,040
Market Cap Growth	-16.27%	-1.76%	-76.54%	-27.49%	100.53%	15.15%
Enterprise Value	140,981	142,444	141,972	399,730	505,705	262,672
Last Close Price	1951.00	2090.00	2555.00	13038.48	18805.50	10790.77
PE Ratio	-	-2.50	-1.42	-7.40	-29.42	-22.39
PS Ratio	1.22	1.37	1.34	5.27	5.18	3.83
PB Ratio	1.38	1.31	0.87	3.43	4.07	2.32
P/FCF Ratio	-5.47	-4.96	-5.14	-10.61	-13.20	-3.42
P/OCF Ratio	-5.89	-5.78	-7.05	-12.92	-37.68	-39.21
EV/Sales Ratio	2.36	2.51	2.39	6.22	5.61	4.31
EV/EBITDA Ratio	-10.07	-7.62	-7.52	-17.89	-59.43	-95.33
EV/EBIT Ratio	-6.44	-5.14	-5.24	-13.27	-32.56	-41.20
EV/FCF Ratio	-8.92	-9.05	-9.17	-12.52	-14.29	-3.85
Debt / Equity Ratio	1.41	1.28	0.95	0.75	0.51	0.84
Debt / FCF Ratio	-4.82	-4.85	-5.62	-2.32	-1.66	-1.24
Asset Turnover	0.36	0.29	0.27	0.31	0.44	0.37
Inventory Turnover	4.57	4.71	4.72	4.75	5.50	4.58
Quick Ratio	0.18	0.17	0.57	0.66	0.81	1.39
Current Ratio	0.35	0.33	0.73	1.07	1.28	1.82
Return on Equity (ROE)	-37.46%	-42.65%	-44.66%	-35.97%	-11.30%	-9.36%
Return on Assets (ROA)	-9.20%	-8.88%	-7.70%	-9.17%	-4.77%	-2.41%
Return on Capital (ROIC)	-10.96%	-11.01%	-9.63%	-10.87%	-5.42%	-2.74%
Earnings Yield	-32.69%	-40.23%	-52.54%	-11.26%	-2.70%	-3.76%
FCF Yield	-21.68%	-20.16%	-19.47%	-9.42%	-7.57%	-29.26%
Buyback Yield / Dilution	-22.15%	-61.23%	-7.58%	-9.71%	-8.69%	-14.84%
Total Shareholder Return	-22.15%	-61.23%	-7.58%	-9.71%	-8.69%	-14.84%

Source: S&P Capital IQ. Standard template. Financial Sources.